Form 8-K - Current report:
SEC Accession No. 0001104659-24-107052
Filing Date
2024-10-08
Accepted
2024-10-08 16:30:26
Documents
15
Period of Report
2024-10-07
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2425756d1_8k.htm   iXBRL 8-K 32292
2 EXHIBIT 99.1 tm2425756d1_ex99-1.htm EX-99.1 19616
6 GRAPHIC tm2425756d1_ex99-1img001.jpg GRAPHIC 2662
  Complete submission text file 0001104659-24-107052.txt   240622

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ganx-20241007.xsd EX-101.SCH 3039
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ganx-20241007_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ganx-20241007_pre.xml EX-101.PRE 22375
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2425756d1_8k_htm.xml XML 3794
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 241360648
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)